OPOLIMOGENE CAPMILISBAC
UNII 2O95SM11L5

Substance Identification & Data

This profile provides standardized clinical and technical data for Opolimogene Capmilisbac, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2O95SM11L5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
2O95SM11L5
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
OPOLIMOGENE CAPMILISBAC
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C125631
National Cancer Institute reference terminology for clinical and research data.
INN ID
10547
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
FG-88
Identifier assigned by the United States Adopted Names Council.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Opolimogene Capmilisbac. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

OPOLIMOGENE CAPMILISBAC

Common Names & Synonyms

OPOLIMOGENE CAPMILISBAC [INN]
OPOLIMOGENE CAPMILISBAC [USAN]

Systematic Nomenclature

THE N-TERMINAL 100 AMINO ACIDS OF THE LM ACTA (ACTIN-ASSEMBLY INDUCING PROTEIN PRECURSOR) PROTEIN (ACTAN100), 5 TANDEM COPIES OF A 21 AMINO ACID FRAGMENT OF HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III (EGFRVIII) AND HUMAN PROTEIN SSX2 (SYNOVIAL SARCOMA, X BREAKPOINT 2, ALSO KNOWN AS CANCER/TESTIS ANTIGEN 5.2 (CT5.2), TUMOR ANTIGEN HOMMEL-40), UNDER THE CONTROL OF THE LM ACTA PROMOTER, AND CONTAINED WITHIN AN EXPRESSION CASSETTE OF 1434 BP INSERTED AT THE ACTA LOCUS
THE N-TERMINAL 100 AMINO ACIDS OF THE LM ACTA PROTEIN (ACTAN100), 5 TANDEM COPIES OF A 21 AMINO ACID FRAGMENT OF HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III (EGFRVIII) AND AMINO ACIDS 11-234 OF HUMAN HOMEOBOX PROTEIN NKX-3.1 (NKX3-1) PLUS AMINO ACIDS 1-20, 44- 138 AND 169-750 OF HUMAN GLUTAMATE CARBOXYPEPTIDASE 2 (ALSO KNOWN AS FOLATE HYDROLASE 1 (FOLH1), PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)), UNDER THE CONTROL THE LM ACTA PROMOTER, AND CONTAINED WITHIN AN EXPRESSION CASSETTE OF 4984 BP AT THE TRNAARG LOCUS
THE N-TERMINAL 100 AMINO ACIDS OF THE LM ACTA PROTEIN (ACTAN100), 5 TANDEM COPIES OF A 21 AMINO ACID FRAGMENT OF HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III (EGFRVIII) AND AMINO ACIDS 33-386 OF HUMAN PROSTATIC ACID PHOSPHATASE (PAP), UNDER THE CONTROL THE LM ACTA PROMOTER, AND CONTAINED WITHIN AN EXPRESSION CASSETTE OF 2057 BP INSERTED AT THE INLB (INTERNALIN B) LOCUS

Technical Codes

ADU-741
JNJ-64041809

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus